Yearly Archives: 2026

A new report from the All-Party Parliamentary Group (APPG) on Pharmacy urges Government to publish its long-overdue response on pharmacist flexibilities and review pharmacy reimbursement. Published today, the report assesses progress on supply issues since the APPG’s Inquiry into Medicines Shortages in England in July 2025. Drawing on evidence from stakeholders across the supply chain, [...]

The post MPs call for pharmacist flexibilities and reimbursement review appeared first on Community Pharmacy England.

Community Pharmacy England has called for a greater focus on getting the most from existing pharmacy services before the sector takes on further expansion at the 2026 Pharmacy Show. In a keynote update, our Chief Executive Janet Morrison reflected on the pressures facing pharmacy businesses, the value they already deliver for patients and the NHS, [...]

The post CPE at Pharmacy Show: Pharmacy must optimise existing services before taking on more appeared first on Community Pharmacy England.

National Patient Safety Alert: StatStrip® beta-ketone testing strips (Nova Biomedical) National Patient Safety Alert Reference Number: NatPSA/2026/007/NSDR Date issued: 13 October 2026 Explanation of identified safety issue Nova has identified quality issues affecting specified lots of StatStrip ketone test strips. The affected lots have been associated with quality-control (QC) failures and Nova has initiated a [...]

The post National Patient Safety Alert: StatStrip® beta-ketone testing strips (Nova Biomedical) appeared first on Community Pharmacy England.

NHS England’s Getting It Right First Time (GIRFT) programme has launched the first national online pathway and decision-making tool for the care of adult patients presenting with headache symptoms, supporting pharmacy and GP teams to offer good headache management and care. The simple format guides pharmacy teams through assessment, management and treatment options (where appropriate), [...]

The post NHS England webinar: Launch of national online pathway for headache care appeared first on Community Pharmacy England.

MHRA Class 2 Medicines Recall: Pedmarqsi 80 mg/mL solution for infusion (Norgine Pharmaceuticals Limited) Drug alert number: EL(26)A/42 Date issued: 12 October 2026 Norgine Pharmaceuticals Limited is recalling the batches listed in the table due to risk of particulate matter being present in the product identified during routine stability investigations. DMRC reference number: DMRC-41054154 Company name: [...]

The post MHRA Class 2 Medicines Recall: Pedmarqsi 80 mg/mL solution for infusion (Norgine Pharmaceuticals Limited) appeared first on Community Pharmacy England.